Influence of cryogenic temperatures on inflammatory markers in patients with ankylosing spondylitis

• Autorzy: Stanek A , Cieslar G. , Strzelczyk J. , Kasperczyk S. , Sieron-Stoltny K. , Wiczkowski A. , Birkner E. , Sieron A.
• Języki publikacji: EN

Abstrakty

EN

The aim of this study was to estimate the influence of cryogenic temperatures used for whole-body cryotherapy on inflammatory markers in patients with ankylosing spondylitis (AS) and healthy volunteers. The study involved 32 male persons: 16 patients with AS and 16 healthy volunteers. All subjects were exposed to a cycle of 10 daily procedures of whole-body cryotherapy at a temperature of -120°C lasting 2 minutes with subsequent kinesitherapy. In both groups, before and after a cycle of whole-body cryotherapy with subsequent kinesitherapy, serum C-reactive protein, fibrinogen, mucoprotein, soluble intercellular adhesion molecule-1levels and erythrocyte sedimentation rate were estimated. The results of this study indicate that cryogenic temperatures used for whole-body cryotherapy decrease the levels of inflammatory markers both in patients with ankylosing spondylitis and healthy volunteers.

Słowa kluczowe

EN

cryogenic temperature; cryotherapy; innflammatory marker; C-reactive protein; mucoprotein; human disease; ankylosing spondylitis; patient; soluble intercellular adhesion molecule-1

• Wydawca: -
• Czasopismo: Polish Journal of Environmental Studies
• Rocznik: 2010
• Tom: 19
• Numer: 1
• Opis fizyczny: p.167-175,fig.,ref.

Twórcy

autor

Stanek A

• Medical University of Silesia, Batorego 15, 41-902 Bytom, Poland

autor

Cieslar G.

autor

Strzelczyk J.

autor

Kasperczyk S.

autor

Sieron-Stoltny K.

autor

Wiczkowski A.

autor

Birkner E.

autor

Sieron A.

Bibliografia

• 1. ALBU A., PARASCA I., TALU S., POANTA L. Ankylosing spondylitis - a systemic disease. Rom. J. Intern. Med. 42, 685, 2004.
• 2. GAUSE A., SCHNABEL A. Rheumatology 2003 - part I: research news concerning pathogenesis, epidemiology, diagnosis, and therapy of chronic inflammatory joint diseases. Med. Klin. 98, 523, 2003.
• 3. KATARIA R.K., BRENT L.H: Spondyloarthropathies. Am. Fam. Physician 69, 2853, 2004.
• 4. KIM T.H., UHM W.S., INMAN R.D. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr. Opin. Rheumatol. 17, 400, 2005.
• 5. MARKER-HERMANN E. FRAUENDORF E., ZEIDLER H., SIEPER J. Pathogenesis of ankylosing spondylitis - mechanisms of disease manifestation and chronicity. Z. Rheumatol. 63, 187, 2004.
• 6. REVEILLE J.D., ARNETT F.C. Spondyloarthritis: update on pathogenesis and management. Am. J. Med. 118, 592, 2005.
• 7. SIEPER J. Spondyloarthritis. Z. Rheumatol. 6, 185, 2004.
• 8. ANALAY Y., OZCAN E., KARAN A., DIRACOGLU D., AYDIN R. The effectiveness of intensive group exercise on patients with ankylosing spondylitis. Clin. Rehabil. 17, 631, 2003.
• 9. DAGFINRUD H., KVIEN T.K., HAGEN K.B. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst. Rev. 4, CD002822, 2004.
• 10. FRANSEN M. When is physiotherapy appropriate? Best Pract. Res. Clin. Rheumatol. 18, 477, 2004.
• 11. METZGER D., ZWINGMANN C., PROTZ W., JACKEL W.H. Whole-body cryotherapy in rehabilitation of patients with rheumatoid diseases – pilot study. Rehabilitation 39, 93, 2000.
• 12. SMIDT N., DE VET H.C., BOUTER L.M., DEKKER J., ARENDZEN J.H., DE BIE R.A., BIERMA-ZEINSTRA S.M., HELDERS P.J., KEUS S.H., KWAKKEL G., LENSSEN T., OOSTENDORP R.A., OSTELO R.W., REIJMAN M., TERWEE C.B., THEUNISSEN C., THOMAS S., VAN BAAR M.E., VAN 'T HUL A., VAN PEPPEN R.P., VERHAGEN A., VAN DER WINDT D.A. Effectiveness of exercise therapy: a best-evidence summary of systematic reviews. Aust. J. Physiother. 51, 71, 2005.
• 13. VLAK T. Spondyloarthropathies - clinical evaluation and physical therapy. Reumatism 51, 29, 2004.
• 14. YURTKURAN M., AY A., KARAKOC Y. Improvement of clinical outcome in ankylosing spondylitis by balneotherapy. Joint Bone Spine 72, 303, 2005.
• 15. OLSON J.E., STAVRINO V.D. A review of cryotherapy. Phys. Ther. 52, 840, 1972.
• 16. FRICKE R. Ganzkorperkaltetherapie. Z. Phys. Med. Baln. Med. Klin. 15, 311, 1989.
• 17. ZAGROBELNY Z. (Ed.). Whole-body and local cryotherapy; Wydawnictwo Medyczne Urban & Partner, Wrocław 2003 [In Polish].
• 18. PODBIELSKA H., STRĘK W., BIAŁY D. (eds.). Acta of Biomedical Engineering: Whole Body Cryotherapy; Indygo Zahir Media, Wrocław 2007.
• 19. SIEROŃ A., CIEŚLAR G. (Eds.). Cryotherapy – therapeutic application of cold; α-medica press: Bielsko-Biała, 2007 [In Polish].
• 20. KNIGHT K.L. Cryotherapy in sport injury management; Human Kinetics: Champaign, 1995.
• 21. JONDERKO G. Current state of knowledge about the application of cryotherapy for treatment of musculoskeletal diseases. Chir. Narz. Ruchu Ortop. Pol. 55, 31, 1990 [In Polish].
• 22. ZGRADIC I., DINIC S., POPOVIC R. Personal experience in cryotherapy treatment. Med. Pregl. 40, 29, 1987.
• 23. SKRZEP-POLOCZEK B., WIŚNIOWSKA B., ROMUK E., BIRKNER E., JAGODZIŃSKI L., STANEK A., SIEROŃ A. The effects of whole-body cryotherapy on ankylotic spondylitis patients. In: Ring H. (Ed.). Proceedings of 2nd World Congress of the International Society of Physical and Rehabilitation Medicine – ISPRM “Reflection on Advances in Rehabilitation – Future Challenges”; 2003 May 18-22; Prague; Monduzzi Editore: Bologne, pp. 391-395, 2003.
• 24. YAMAUCHI T., NOGAMI S., MIURA K. Various applications of extreme cryotherapy and strenuous exercise program - focusing on chronic rheumatoid arthritis. Physiother. Rehab. 5, 35, 1981.
• 25. GREGOROW H. Whole body cryotherapy - indications and contraindications, the procedure and its clinical and physiological effects. Acta Bio-Opt. Inform. Med. 4, 119, 1998.
• 26. VAN DER LINDEN S., VALKENBURG H.A., CATS A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27, 381, 1984.
• 27. BRAUN J, GOLDER W, BOLLOW M, SIEPER J, VAN DER HEIJDE D. Imaging and scoring in ankylosing spondylitis. Clin. Exp. Rheumatol., 20, (28), 178, 2002.
• 28. ROBERTSON V.J., CHIPCHASE L.S., LAAKSO E.L., WHELAN K.M., MCKENNA L.J. Guidelines for the clinical use of electrophysical agents 2001, Australian Physiotherapy Association: Victoria, 2001.
• 29. JOCH W., UCKERT S. Ausdauerleistung nach Kalteapplikation. Leistungssport 33, 17, 2003.
• 30. DOWNTON S.B., COLTON H.R. Acute phase reactants in inflammation and infection. Seminars Hematol. 25, 84, 1988.
• 31. DE LA HUERGA J., DUBIN A., KUSHNER D.S., DYNIEWICZ H.A., POPPER H. Studies of serum mucoprotein (seromucoid). I. A turbidimetric method. J. Lab. Clin. Med. 47, 403, 1956.
• 32. THOMAS L. Clinical and laboratory diagnostics, 5th ed.; TH Books Verlags GmbH: Frankfurt/Main, 1998.
• 33. BAL A., UNLU E., BAHAR G., AYDOG E., EKSIOGLU E., YORGANCIOGLU R. Comparison of serum IL-1beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. Clin. Rheumatol. 26, 211, 2006.
• 34. LIU B., GUO C.Y., LIU W.Q., WU N., XING Q. The value of erythrocyte sedimentation rate and C-reactive protein in evaluating disease activity in ankylosing spondylitis. Zhonghua Nei Ke Za Zhi 44, 566, 2005.
• 35. YILDIRIM K., ERDAL A., KARATAY S., MELIKOGLU M.A., UGUR M., SENEL K. Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis. South Med. J. 97, 350, 2004.
• 36. ROTHELIN R., DUSTIN M.L., MARLIN S.D., SPRINGER T. A human intracellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 37, 1270, 1986.
• 37. STAUNTON D.E., MARLIN S.D., STRATOWA C., DUSTIN M.L., SPRINGER T.A. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52, 925, 1988.
• 38. DUSTIN M.L., ROTHLEIN R., BHAN A.K., DINARELLO C.A., SPRINGER T.A. Induction by IL-1 and interferon-gamma: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J. Immunol. 137, 245, 1986.
• 39. POTOCNIK A.J., KINNE R., MENNINGER H., ZACHER J., EMMRICH F., KROCZEK R.A. Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand. J. Immunol. 31, 231, 1990.
• 40. KLIMIUK P.A., FIEDORCZYK M., SIERAKOWSKI S., CHWIECKO J. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. Scand. J. Rheumatol. 36, 345, 2007.
• 41. KOCH A.E., SHAH M.R., HARLOW L.A., LOVIS M.R., POPE R.M. Soluble intercellular adhesion molecule-1 in arthritis. Clin. Immunol. Immunopathol. 71, 208, 1994.
• 42. COGALGIL S., TAYSI S. Levels of antioxidant proteins and soluble intercellular adhesion molecule-1 in serum of patients with rheumatoid arthritis. Ann. Clin. Lab. Sci. 32, 264, 2002.
• 43. WENDLING D., RACADOT E., AUGE B., TOUSSIROT E. Soluble intercellular adhesion molecule 1 in spondylarthropathies. Clin. Rheumatol. 17, 202, 1998.
• 44. BANFI G., MELEGATI G., BARASSI A., DOGLIOTTI G., D’ERIL G., DUGUE B., CORSI M. Effects of wholebody cryotherapy on serum mediators of inflammation and serum muscle enzymes in athletes. J. Thermal Biol., 34, 55, 2009.
• 45. RHIND S.G., CASTELLANI J.W., BRENNER I.K., SHEPHARD R.J., ZAMECNIK J., MONTAIN S.J., YOUNG A.J., SHEK P.N. Intracellular monocyte and serum cytokine expression is modulated by exhausting exercise and cold exposure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R66, 2001.
• 46. WOŹNIAK A., MILA-KIERZENKOWSKA C., DREWA T., DREWA G., WOŹNIAK B., OLSZEWSKA D., MALINOWSKI D., RAKOWSKI A., BRZUCHALSKI M. Activity of chosen lysosome′s enzymes in plasma of canoeists after whole-body cryotherapy. Med. Sport. 17, 322, 2001 [In Polish].
• 47. KOSTULAK A. The effect of ACTH and cortisone on the behavior of arylsulphatases in the salivary glands of hite rat. Acta Histochem. 58, 63, 1977.
• 48. TONCSEY H., FRENKL R. Studies on the lysosomal enzyme system of the liver in rats undergoing swimming training. Int. J. Sports Med. 5, 152, 1984.
• 49. ZAGROBELNY Z., HALAWA B., JEZIERSKI C., WAWROWSKA A. The influence of a single whole body cryostimulation on selected hemodynamic indices and hormone concentrations in the serum of healthy individuals. Pol. Tyg. Lek. 48, 303, 1993 [In Polish].
• 50. ZAGROBELNY Z., HALAWA B., NEGRUSZ-KAWECKA M., SPRING A., GREGOROWICZ H., WAWROWSKA A., ROZWADOWSKI G. Hormonal and hemodynamic changes caused by whole body cooling in patients with rheumatoid arthritis. Pol. Arch. Med. Wewn. 87, 34, 1992 [In Polish].
• 51. WOŹNIAK A., WOŹNIAK B., DREWA G., MILAKIERZENKOWSKA C., RAKOWSKI A. The effect of whole-body cryostimulation on lysosomal enzyme activity in kayakers during training. Eur. J. Appl. Physiol. 100, 137, 2007.
• 52. LEPPALUOTO J., WESTERLUND T., HUTTUNEN P., OKSA J., SMOLANDER J., DUGUE B., MIKKELSSON M. Effects of long-term whole-body cold exposures on plasma concentrations of ACTH, beta-endorphin, cortisol, catecholamines and cytokines in healthy females. Scand. J. Clin. Lab. Invest. 68, 145, 2008.
• 53. OLLINGER K. BRUNK U.T. Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Radic. Biol. Med. 19, 565, 1995.
• 54. STANEK A., CIEŚLAR G., BIRKNER E., JAGODZIŃSKI L., SKRZEP-POLOCZEK B., ROMUK E., SIEROŃ A. Changes in antioxidant status in patients with ankylosing spondylitis during cryotherapy. Eur. J. Clin. Invest. 35, (2), 26, 2005.
• 55. LUBKOWSKA A., CHUDECKA M., KLIMEK A., SZYGUŁA Z., FRĄCZEK B. Acute effect of a signal whole-body cryostimulation on prooxidant-antioxidant balance in blood of healthy, young men. J. Thermal. Biol. 33, 464, 2008.
• 56. WOŹNIAK A., WOŻNIAK B., DREWA G., MILAKIERZENKOWSKA C. The effect of cryostimulation on the prooxidant-antioxidant balance in blood of elite kayakers after training. Eur. J. Appl. Physiol. 101, 533, 2007.
• 57. JANISZEWSKI M. Cryotherapy as a factro supportong rehabilitation. Med. Sport. 2, 57, 1998 [In Polish].
• 58. URSO M.L., CLARKSON P.M. Oxidative stress, exercise, and antioxidant supplementation. Toxicology, 189, 41, 2003.
• 59. STANEK A., CIEŚLAR G., MATYSZKIEWICZ B., ROSMUS-KUCZIA I., SIEROŃ-STOŁTNY K., KOCZY B., SIEROŃ A. Subjective estimation of therapeutic efficacy of whole-body cryotherapy in patients with ankylosing spondylitis. Balneol. Pol. 47, 24, 2005 [In Polish].
• 60. STANEK A., SIEROŃ A., CIEŚLAR G., MATYSZKIEWICZ B., ROSMUS-KUCZIA I. Influence of whole-body cryotherapy on parameters of spine mobility in patients with ankylosing spondylitis. Ortop. Traumat. Rehab. 7, 549, 2005 [In Polish